These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
322 related items for PubMed ID: 21051740
1. Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. Dragon-Durey MA, Sethi SK, Bagga A, Blanc C, Blouin J, Ranchin B, André JL, Takagi N, Cheong HI, Hari P, Le Quintrec M, Niaudet P, Loirat C, Fridman WH, Frémeaux-Bacchi V. J Am Soc Nephrol; 2010 Dec; 21(12):2180-7. PubMed ID: 21051740 [Abstract] [Full Text] [Related]
2. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome. Diamante Chiodini B, Davin JC, Corazza F, Khaldi K, Dahan K, Ismaili K, Adams B. Pediatrics; 2014 Jun; 133(6):e1764-8. PubMed ID: 24843055 [Abstract] [Full Text] [Related]
3. Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS. Dragon-Durey MA, Blanc C, Garnier A, Hofer J, Sethi SK, Zimmerhackl LB. Semin Thromb Hemost; 2010 Sep; 36(6):633-40. PubMed ID: 20865640 [Abstract] [Full Text] [Related]
4. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Józsi M, Strobel S, Dahse HM, Liu WS, Hoyer PF, Oppermann M, Skerka C, Zipfel PF. Blood; 2007 Sep 01; 110(5):1516-8. PubMed ID: 17495132 [Abstract] [Full Text] [Related]
5. Complement activation in diseases presenting with thrombotic microangiopathy. Meri S. Eur J Intern Med; 2013 Sep 01; 24(6):496-502. PubMed ID: 23743117 [Abstract] [Full Text] [Related]
12. Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome. Nozal P, Bernabéu-Herrero ME, Uzonyi B, Szilágyi Á, Hyvärinen S, Prohászka Z, Jokiranta TS, Sánchez-Corral P, López-Trascasa M, Józsi M. Mol Immunol; 2016 Feb 01; 70():47-55. PubMed ID: 26703217 [Abstract] [Full Text] [Related]
13. [Clinical characteristies of atypical hemolytie uremic syndrome associated with H factor antibody in children]. Guan N, Liu X, Yao Y, Yang J, Wang F, Xiao H, Ding J, Zhao M, Yu F, Wang F. Zhonghua Er Ke Za Zhi; 2014 Mar 01; 52(3):223-6. PubMed ID: 24824395 [Abstract] [Full Text] [Related]
14. Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database. Puraswani M, Khandelwal P, Saini H, Saini S, Gurjar BS, Sinha A, Shende RP, Maiti TK, Singh AK, Kanga U, Ali U, Agarwal I, Anand K, Prasad N, Rajendran P, Sinha R, Vasudevan A, Saxena A, Agarwal S, Hari P, Sahu A, Rath S, Bagga A. Front Immunol; 2019 Mar 01; 10():1282. PubMed ID: 31231391 [Abstract] [Full Text] [Related]
19. The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome. Song D, Liu XR, Chen Z, Xiao HJ, Ding J, Sun SZ, Liu HY, Guo WY, Wang SX, Yu F, Zhao MH, Chinese Renal–TMA Network Institutes. Pediatr Nephrol; 2017 May 01; 32(5):811-822. PubMed ID: 28035470 [Abstract] [Full Text] [Related]
20. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system]. Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C. Rev Med Interne; 2011 Apr 01; 32(4):232-40. PubMed ID: 21376430 [Abstract] [Full Text] [Related] Page: [Next] [New Search]